As the largest independent funder of MND/ALS research in Australia, FightMND’s vision is a world without MND. Integral in this vision is our determination to help facilitate the translation of the growing body of new knowledge about the disease into treatments and ultimately a cure for MND/ALS patients internationally. FightMND offers funding opportunities for both national and international researchers through a number of research schemes. Grant criteria and conditions are detailed below.

RESEARCH GRANT CRITERIA

Researchers working in areas relevant to improving the translation of/or progressing the development of potential therapies for Motor Neurone Disease (MND) are invited to apply for funding to support research projects commencing in 2021.

We are pleased to announce a call for the following FightMND Research Grants.

Clinical Trial Grants

These grants support Phase II/III clinical trials of novel, high-potential treatments for MND/ALS within the Australian Clinical Trials Consortium.

Click here to download a copy of the Clinical Trial Grants Criteria

Click here to download the Clinical Trial Grants Coversheet

These grants are awarded with an offer of up to AUD $1,500,000 (Phase II/III trial) with a project performance of up to 3 years.

Eligibility: Applications are open to MND/ALS researchers globally. Australian trial sites mandatory.

 KEY DATES

  • Applications Open: 30 October 2020
  • Letter of Intent due: 15 January 2021
  • Submit Letter of Intent to: researchgrants@fightmnd.org.au
  • Invitation to submit full application: 1 February 2021
  • Full application due: 1 April 2021 at 17:00 AEDT
  • Recipients Notified: August 2021

Drug Development Grants

These grants support the preclinical research, development and assessment of therapeutics for MND/ALS through to (and including) completion of Phase I clinical trials.

Click here to download a copy of the Drug Development Grants Criteria

Click here to download the Drug Development Grants Coversheet

These grants are each awarded with an offer of up to AUD $1,000,000 in support available for 3-year projects (Projects with a period of performance of less than 3-years will also be considered).

Eligibility: Applications are open to MND/ALS researchers globally.

KEY DATES

  • Applications Open: 30 October 2020
  • Letter of Intent due: 15 January 2021
  • Submit Letter of Intent to: researchgrants@fightmnd.org.au
  • Invitation to submit full application: 1 February 2021
  • Full application due: 1 April 2021 at 17:00 AEDT
  • Recipients Notified: August 2021

IMPACT Grants

IMPACT (IMProving and ACcelerating Translation) Grants support projects focused on one or more of the following key issues contributing to the lack of translation of effective treatments through to clinical trial for MND/ALS:

  1. Disease heterogeneity
  2. Lack of relevant preclinical models
  3. A lack of reliable disease biomarkers
  4. The challenge of drug delivery into the brain
  5. A lack of effective targeted gene therapies
  6. The untapped potential of stem cell therapy

Click here to download a copy of the IMPACT Grant Criteria

Click here to download the IMPACT Grants Coversheet

These grants are for support of 2-year projects up to the value of AUD $250,000. Proposals for both discovery and translational research stages will be considered. 

Eligibility: Applications are invited for research based in institutions within Australia. Investigators at all academic levels are eligible to submit applications.

Please note that applicants are limited to one (1) CIA and two (2) Co-CI applications for this grant scheme.

KEY DATES

  • Applications Open: 30 October 2020
  • Full application due: 1 April 2021 at 17:00 AEDT
  • Recipients Notified: August 2021

Angie Cunningham FightMND PhD Scholarship and Project Grant-in-Aid

FightMND call for proposals: PhD Scholarship and Grant-in-Aid applications for novel, innovative projects aimed at understanding the causes of sporadic MND, elucidating disease mechanisms and/or tackling one or more key issues contributing to the lack of effective treatments for sporadic MND.

Click here to download a copy of the Angie Cunningham PhD Grant Criteria

Click here to download the Angie Cunningham PhD Coversheet

FightMND will provide:

A total of $100,000 AUD per annum for a 3-year Scholarship and Project Grant-in-Aid. This funding comprises;

  • A student stipend of $30,000 per annum;
  • A total budget of $5,000 per annum for travel and conference attendance;
  • $65,000 per annum in project and laboratory expenses (Grant-in-Aid); and
  • Following approval by the FightMND, a further 6 months of funding to the value of $50,000 is available for PhD projects extending to a 3.5-year duration.

Eligibility: Applications are invited from prospective supervisors and PhD students based in research institutions in Australia. The principal supervisor must have demonstrable experience of supervising PhD students.

KEY DATES

  • Applications Open: 30 October 2020
  • Full application due: 1 February 2021 at 17:00 AEDT
  • Recipients Notified: March 2021

Please see individual grant application guidelines for further information or for further enquiries, please contact Dr Davor Stanic, FightMND Research Coordinator, researchgrants@fightmnd.org.au